These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. "30-minute-delta" of high-sensitivity troponin I improves diagnostic performance in acute myocardial infarction. Yokoyama H; Higuma T; Endo T; Nishizaki F; Hanada K; Yokota T; Yamada M; Okumura K; Tomita H J Cardiol; 2018 Feb; 71(2):144-148. PubMed ID: 28941733 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome. Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial Infarction. Sörensen NA; Ludwig S; Makarova N; Neumann JT; Lehmacher J; Hartikainen TS; Haller PM; Keller T; Blankenberg S; Westermann D; Zeller T; Schofer N Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31505902 [No Abstract] [Full Text] [Related]
11. Time from symptom onset influences high-sensitivity troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. Guangquan L; Hualan H; Xin N; Yong H; Haolan S; Tongxing L; Baoxiu G; Hu N; Guixing L Clin Chem Lab Med; 2016 Jan; 54(1):133-42. PubMed ID: 26124053 [TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes. Peiró ÓM; Cediel G; Bonet G; Rojas S; Quintern V; Carrasquer A; González-Del-Hoyo M; Sanz E; Bardají A Biomarkers; 2020 Jul; 25(5):402-409. PubMed ID: 32551985 [No Abstract] [Full Text] [Related]
16. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study. Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986 [TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancer. Rasmussen LJH; Schultz M; Iversen K; Eugen-Olsen J; Helms M; David K; Kjaer A; Lebech AM; Kronborg G Clin Biochem; 2020 Oct; 84():31-37. PubMed ID: 32504704 [TBL] [Abstract][Full Text] [Related]
18. The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexes. Möckel M; Heller G; Berg K; Klefisch F; Danne O; Müller C; Störk TV; Frei U; Wu AH Clin Chim Acta; 2000 Mar; 293(1-2):139-55. PubMed ID: 10699429 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. Neumann JT; Sörensen NA; Schwemer T; Ojeda F; Bourry R; Sciacca V; Schaefer S; Waldeyer C; Sinning C; Renné T; Than M; Parsonage W; Wildi K; Makarova N; Schnabel RB; Landmesser U; Mueller C; Cullen L; Greenslade J; Zeller T; Blankenberg S; Karakas M; Westermann D JAMA Cardiol; 2016 Jul; 1(4):397-404. PubMed ID: 27438315 [TBL] [Abstract][Full Text] [Related]
20. Rapid rule out of acute myocardial infarction in the observe zone using a combination of presentation N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin I. Wang Y; Dai L; Wang N; Zhu Y; Chen M; Wang H Clin Biochem; 2019 Aug; 70():34-38. PubMed ID: 31173734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]